The US markets ended lower on Monday on profit taking following the strength seen in the markets over the past few sessions. Negative sentiment also generated in reaction to a report from the National Association of Realtors showing pending home sales in the US unexpectedly decreased in the month of October, according to a report released by the National Association of Realtors (NAR). NAR said its pending home sales index slid by 1.1 percent to 128.9 in October after tumbling by 2.0 percent to a revised 130.3 in September. The continued decline came as a surprise to economists, who had expected pending home sales to jump by 1.0 percent compared to the 2.2 percent slump originally reported for the previous month. Despite falling for two straight months, pending home sales in October were still up by 20.2 percent compared to the same month a year ago.
Meanwhile, traders largely shrugged off the latest upbeat news regarding a potential coronavirus vaccine, with Moderna announcing that a phase 3 trial of its vaccine candidate indicates an efficacy of 94.1 percent. The biotechnology company said it plans to request an Emergency Use Authorization from the FDA and conditional approval from the European Medicines Agency.
Dow Jones Industrial Average fell 271.73 points or 0.91 percent to 29,638.64, Nasdaq dropped 7.11 points or 0.06 percent to 12,198.74 and S&P 500 was down by 16.72 points or 0.46 percent 3,621.63.
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: